Oxford BioDynamics (LON:OBD) Receives House Stock Rating from Shore Capital

Shore Capital reiterated their house stock rating on shares of Oxford BioDynamics (LON:OBDFree Report) in a report issued on Tuesday, Marketbeat Ratings reports.

Oxford BioDynamics Stock Performance

LON OBD opened at GBX 8.55 ($0.11) on Tuesday. The company has a current ratio of 1.79, a quick ratio of 2.80 and a debt-to-equity ratio of 106.34. The business’s 50 day moving average is GBX 8.40 and its two-hundred day moving average is GBX 16.19. Oxford BioDynamics has a 12-month low of GBX 7.50 ($0.10) and a 12-month high of GBX 52 ($0.67). The stock has a market capitalization of £26.66 million, a price-to-earnings ratio of -124.14 and a beta of 0.46.

Oxford BioDynamics Company Profile

(Get Free Report)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.

Recommended Stories

Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.